Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-28, Stock:PFE, The news for the past five days is as follows:
2019-06-21: NEWS1: Amag’s plan to bypass female libido drug pitfalls? Social media..NEWS2: Dow Jones Today: A Typical Summer Friday.NEWS3: Oh, By the Way, This Clinical Trial Didn't Work.NEWS4: Oh, By the Way, This Clinical Trial Didn't Work.NEWS5: Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA.NEWS6: Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod.NEWS7: Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up.NEWS8: Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up.NEWS9: Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma.NEWS10: Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma.NEWS11: European Commission Approves TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer.NEWS12: Health Care Sector Update for 06/21/2019: CTRV, OCUL, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 06/21/2019: CTRV, OCUL, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma.NEWS15: Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up.NEWS16: Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod.
2019-06-24: NEWS1: Why These Innovative Biotech ETFs Soaring.NEWS2: Why These Innovative Biotech ETFs Soaring.NEWS3: Comparing PFE’s and BMY’s Revenue Trajectory.NEWS4: Why These Innovative Biotech ETFs Soaring.NEWS5: This Biotech Stock Is Facing A 'Whale' As Pfizer Unveils Gene Therapy Data.NEWS6: What Analysts Recommend for Pfizer and Bristol-Myers Squibb.NEWS7: BioMarin Gets $15M From Pfizer on Talzenna's European Nod.NEWS8: BioMarin Gets $15M From Pfizer on Talzenna's European Nod.NEWS9: U.S. Senate Takes on Big Tech, Plus &quot;Merger Monday&quot;.NEWS10: Eldorado to Buy Caesars.NEWS11: Pfizer's Talzenna Gets Approval in Europe for Breast Cancer.NEWS12: Pfizer's Talzenna Gets Approval in Europe for Breast Cancer.NEWS13: Read This Before You Buy Any New Cancer Drug Stocks.NEWS14: Read This Before You Buy Any New Cancer Drug Stocks.NEWS15: BioMarin Gets $15M From Pfizer on Talzenna's European Nod.NEWS16: U.S. Senate Takes on Big Tech, Plus &quot;Merger Monday&quot;.NEWS17: Pfizer's Talzenna Gets Approval in Europe for Breast Cancer.
2019-06-25: NEWS1: Stocks Swing Lower As Rate Cut Optimism Dampens.NEWS2: Stocks Swing Lower As Rate Cut Optimism Dampens.NEWS3: Pfizer (PFE) Flat As Market Sinks: What You Should Know.NEWS4: 3 Healthcare Stocks to Buy With the Market Near All-Time Highs.NEWS5: 3 Healthcare Stocks to Buy With the Market Near All-Time Highs.NEWS6: After Hours Most Active for Jun 25, 2019 :  DIS, TI, LC, PFE, NEM, QD.NEWS7: After Hours Most Active for Jun 25, 2019 :  DIS, TI, LC, PFE, NEM, QD.NEWS8: Abbvie Decides to Acquire Allergan.NEWS9: Noteworthy ETF Inflows: SPY, BRK.B, DIS, PFE.NEWS10: Noteworthy ETF Inflows: SPY, BRK.B, DIS, PFE.NEWS11: AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20.NEWS12: Dow Movers: GS, JNJ.NEWS13: Dow Movers: GS, JNJ.NEWS14: Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015.NEWS15: Abbvie Decides to Acquire Allergan.NEWS16: Pfizer’s Oncology Treatment Growth Drivers.NEWS17: AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20.NEWS18: Comparing PFE’s and BMY’s Expense Trends.NEWS19: How PFE’s and BMY’s EPS Trends Compare.NEWS20: Allergan stock surges on news that Abbvie will buy Botox maker in a $63 billion deal.
2019-06-26: NEWS1: 3 Dividend Stocks That Could Pay You the Rest of Your Life.NEWS2: Conatus' Emricasan Lags Primary Goal in Liver Function Study.NEWS3: Conatus' Emricasan Lags Primary Goal in Liver Function Study.NEWS4: Comparing PFE’s and BMY’s Immunology Drugs.NEWS5: Conatus' Emricasan Lags Primary Goal in Liver Function Study.NEWS6: 3 Dividend Stocks That Could Pay You the Rest of Your Life.NEWS7: 3 Dividend Stocks That Could Pay You the Rest of Your Life.NEWS8: Pfizer (PFE) Flat As Market Sinks: What You Should Know.NEWS9: Pfizer (PFE) Flat As Market Sinks: What You Should Know.NEWS10: 3 Biopharma Stocks to Buy for Income.NEWS11: 3 Biopharma Stocks to Buy for Income.
2019-06-27: NEWS1: Pfizer names former FDA chief Scott Gottlieb to its board.NEWS2: Scott Gottlieb Elected to Pfizer’s Board of Directors.NEWS3: Pfizer Declares Third-Quarter 2019 Dividend.NEWS4: Lilly's Study on Higher Doses of Trulicity Meets Endpoint.NEWS5: Lilly's Study on Higher Doses of Trulicity Meets Endpoint.NEWS6: Draper laboratory signs 'organ-on-chip' development deal with Bristol-Myers Squibb.NEWS7: Bayer Sets Up Special Committee to Tackle Glyphosate Lawsuits.NEWS8: Bayer Sets Up Special Committee to Tackle Glyphosate Lawsuits.NEWS9: Lilly's Study on Higher Doses of Trulicity Meets Endpoint.NEWS10: Bayer Sets Up Special Committee to Tackle Glyphosate Lawsuits.NEWS11: Ex-FDA boss joins Pfizer 83 days after leaving US drug regulator.

Answer: Decrease